Avelas Biosciences
Latest round
- Series C
Last raised
- Aug 2016
Total raised
- $35M
Investors
- 8
About Avelas Biosciences
Avelas Biosciences, Inc.Avelas Biosciences specializes in the development of diagnostics for cancer treatment. Avelas is headquartered in the US.Avelas Biosciences offers diagnostic solutions designed to enhance cancer treatment decision-making. Their product suite includes advanced imaging technologies and molecular diagnostics aimed at improving the precision of cancer therapies. These solutions target healthcare providers and oncologists, facilitating better patient outcomes through personalized treatment approaches.Avelas Biosciences generates revenue through a combination of product sales and partnerships with healthcare institutions. Their financial model is built on transactional sales of diagnostic products, in addition to collaborative agreements with medical facilities that enhance service offerings.Avelas Biosciences is focused on expanding its portfolio with new diagnostic products aimed at enhancing cancer treatment effectiveness. The company plans to introduce additional technologies by 2025, targeting new markets in Europe and Asia to broaden its global reach.000 mn will support these initiatives, particularly in product development and market expansion efforts, enhancing their capacity to deliver innovative solutions in oncology.
Who invested in Avelas Biosciences
8 investors across 4 rounds
See all investors in Avelas Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avelas Biosciences
Who invested in Avelas Biosciences?
Avelas Biosciences has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avelas Biosciences raised?
Avelas Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Avelas Biosciences last raise money?
Avelas Biosciences's most recent round on record is a Series C, in Aug 2016.
What does Avelas Biosciences do?
Avelas Biosciences is a biotechnology company.
Where is Avelas Biosciences headquartered?
Avelas Biosciences is headquartered in US.
Which VCs invest in companies like Avelas Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Avelas Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Avelas Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.